Editorial
Accepted on 07 Nov 2025
Editorial: Mathematical Modeling of Medication Nonadherence
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Type at least 3 characters
2,203 articles
Original Research
Accepted on 07 Nov 2025
Cost-Utility Analysis of PCSK9 Inhibitors for Hypercholesterolemia: A Chinese Healthcare Perspective
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Conceptual Analysis
Accepted on 07 Nov 2025
The night is dark and full of hesitation. The latest step in the legal trajectory of physician-assisted suicide in Italy: through tentative judicial openings, bioethical contradictions and the parliament's deafness
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Original Research
Accepted on 06 Nov 2025
Impact of lymphocyte transformation test (LTT) on the diagnostic accuracy of the culprit drug in drug-induced cytopenias: A case-control study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 115 views
Original Research
Accepted on 06 Nov 2025
Efficacy and Safety of Tranexamic Acid Combined with Low Molecular Weight Heparin versus Fondaparinux Sodium Following Total Knee Arthroplasty: A Retrospective Cohort Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Original Research
Accepted on 05 Nov 2025
Large language models management of complex medication regimens: a case-based evaluation
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 111 views
Review
Accepted on 05 Nov 2025
Medication Adherence in Burn Care: A Systematic Analysis of Barriers and Interventions Using the WHO Framework
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Original Research
Accepted on 03 Nov 2025
Knowledge, Attitudes, and Practices of Inpatients with Chronic Cardiovascular Comorbidities Regarding Polypharmacy: A Cross-Sectional Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 101 views
Original Research
Accepted on 03 Nov 2025
Tuberculosis infection following administration of immune checkpoint inhibitors: a real world observational study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Review
Accepted on 03 Nov 2025
Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Original Research
Accepted on 31 Oct 2025
Cost-effectiveness analysis of irinotecan hydrochloride liposome in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 197 views
Correction
Accepted on 31 Oct 2025
Corrigendum: Cost-effectiveness analysis of cabozantinib plus atezolizumab for advanced hepatocellular carcinoma
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Original Research
Accepted on 30 Oct 2025
Pharmacist Prescriber Implementation in the Experiences of General Practitioners, Pharmacist Prescribers and Patients: Qualitative Study based on Pilot Trial in Slovenia
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Brief Research Report
Published on 30 Oct 2025
Impact on health outcomes and productive work of adding anti-PD-1 agents to treat early-stage cancers in the United Kingdom: a modelling study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613120
- 630 views
Perspective
Published on 28 Oct 2025
Advances in clinical application on nursing intervention for ribavirin-associated adverse events
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596007
- 487 views
Systematic Review
Accepted on 27 Oct 2025
Comparative efficacy and safety of second-line therapies for patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis of randomized controlled trials
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 160 views